Portfolio company
Freecurve
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops molecular simulation software for researchers in drug discovery and materials science to predict the physical behaviour of complex systems.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Rowan
This company develops molecular design and simulation software for scientists working in drug discovery and materials science.
Achira
This company develops atomistic simulation software combining physics and machine learning to enable drug discovery for biotechnology and pharmaceutical organisations.
Deep Origin
This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.
HTuO Biosciences
This company develops AtomForge, a physics-based molecular simulation platform providing drug discovery and lead optimisation services to pharmaceutical and biotechnology partners.
MendelFOLD
This company develops computational protein modelling tools to help pharmaceutical teams and researchers identify drug binding sites and design new medical treatments.
Deep MedChem
This company develops artificial intelligence software for virtual screening and molecular discovery for pharmaceutical, biotechnology and academic drug discovery teams.
POTENTIAL SCIENCES
Potential Sciences develops GPU-native quantum chemistry simulation software for molecular modelling, serving customers in the pharmaceutical and biotechnology sectors.
Kvantify
This company develops quantum and classical computing software for molecular discovery and chemical simulations for life sciences and industrial businesses.
